Conformis Inc. (NASDAQ:CFMS)’s traded shares stood at 2.7 million during the last session, with the company’s beta value hitting 1.37. At the close of trading, the stock’s price was $1.82, to imply an increase of 4.60% or $0.08 in intraday trading. The CFMS share’s 52-week high remains $1.96, putting it -7.69% down since that peak but still an impressive 67.03% since price per share fell to its 52-week low of $0.60. The company has a valuation of $342.87M, with an average of 3.32 million shares in intraday trading volume over the past 10 days and average of 3.55 million shares over the past 3 months.
Analysts have given a consensus recommendation of an Overweight for Conformis Inc. (CFMS), translating to a mean rating of 2.00. Of 4 analyst(s) looking at the stock, 1 analyst(s) give CFMS a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -$0.06.
Conformis Inc. (NASDAQ:CFMS) trade information
After registering a 4.60% upside in the last session, Conformis Inc. (CFMS) has traded red over the past five days. The stock hit a weekly high of 1.9550 this Thursday, 09/16/21, jumping 4.60% in its intraday price action. The 5-day price performance for the stock is 15.92%, and 32.85% over 30 days. With these gigs, the year-to-date price performance is 175.76%. Short interest in Conformis Inc. (NASDAQ:CFMS) saw shorts transact 1.93 million shares and set a 0.62 days time to cover.
Analysts on Wall Street suggest a consensus price target of $2.33, implying an increase of 21.89% to the stock’s current value. The extremes give us $2.00 and $3.00 for target low and target high price respectively. As such, CFMS has been trading -64.84% off suggested target high and -9.89% from its likely low.
Conformis Inc. (CFMS) estimates and forecasts
Looking at statistics comparing Conformis Inc. share performance against respective industry, we note that the company has outperformed competitors. Conformis Inc. (CFMS) shares are 68.52% up over the last 6 months, with its year-to-date growth rate higher than industry average at 79.41% against 17.40%. Revenue is forecast to grow 33.30% this quarter before jumping 25.00% for the next one. The rating firms project that company’s revenue will grow 54.30% compared to the previous financial year.
Revenue forecast for the current quarter as set by 4 analysts is $16.23 million. Meanwhile, for the quarter ending Dec 2021, a total of 4 analyst(s) estimate revenue growth to $19.44 million.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 33.50% for the past 5-year period. While 2021 is set for a 23.70% return in earnings, projections for the next 5 years are at -14.58% annually.
Conformis Inc. has its next earnings report out on May 05. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Conformis Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Conformis Inc. (NASDAQ:CFMS)’s Major holders
Conformis Inc. insiders hold 4.30% of total outstanding shares, with institutional holders owning 50.66% of the shares at 52.94% float percentage. In total, 50.66% institutions holds shares in the company, led by Wasatch Advisors Inc. As of Mar 30, 2021, the company held over 17.72 million shares (or 9.71% of shares), all amounting to roughly $17.54 million.
The next major institution holding the largest number of shares is Consonance Capital Management LP with 13.0 million shares, or about 7.12% of shares outstanding. As of the market price on Mar 30, 2021, these shares were worth $12.87 million.
We also have Wasatch Ultra Growth Fund and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Conformis Inc. (CFMS) shares. Going by data provided on Mar 30, 2021, Wasatch Ultra Growth Fund holds roughly 13.97 million shares. This is just over 7.66% of the total shares, with a market valuation of $13.84 million. Data from the same date shows that the other fund manager holds a little less at 4.45 million, or 2.44% of the shares, all valued at about 4.41 million.